# FDA Inspection 1237367 - Jamie D. Weisman, MD - April 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/jamie-d-weisman-md/041ffb16-b151-4f02-8195-02c3050c7869
Source feed: FDA_Inspections

> FDA Inspection 1237367 for Jamie D. Weisman, MD on April 12, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1237367
- Company Name: Jamie D. Weisman, MD
- Inspection Date: 2024-04-12
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1153855 - 2021-09-24](https://www.keypedia.com/records/fda_inspections/jamie-d-weisman-md/22564a98-f1d4-406a-b6e5-b34901580bb2)
- [FDA Inspection 923595 - 2015-04-01](https://www.keypedia.com/records/fda_inspections/jamie-d-weisman-md/7ea3ba09-9d43-4424-9214-02118381d525)

Company: https://www.keypedia.com/companies/jamie-d-weisman-md/73e6b603-4e7a-4171-bd98-ba5404d250e4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c